(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.17%) $83.71
(-1.16%) $1.619
(0.26%) $2 348.60
(-0.48%) $27.22
(0.41%) $924.25
(0.35%) $0.935
(0.67%) $11.03
(0.14%) $0.800
(-0.25%) $91.94
Live Chart Being Loaded With Signals
Adimmune Corporation manufactures and sells human vaccines in Taiwan. It offers AdimFlu-S, a quadrivalent influenza vaccine; tetanus toxoid alum precipitated product that is used for the prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent influenza vaccines; Quadrivalent influenza vaccine; Influenza A (H1N1) Virus Monovalent Vaccine; Tetanus Toxoid; and purified Tuberculin, as well as contract manufacturing services...
Stats | |
---|---|
Today's Volume | 587 757 |
Average Volume | 1.16M |
Market Cap | 11.62B |
EPS | TWD0 ( 2024-03-13 ) |
Next earnings date | ( TWD0 ) 2024-05-12 |
Last Dividend | TWD0 ( N/A ) |
Next Dividend | TWD0 ( N/A ) |
P/E | -17.80 |
ATR14 | TWD0.0150 (0.06%) |
Volume Correlation
Adimmune Corporation Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Adimmune Corporation Correlation - Currency/Commodity
Adimmune Corporation Financials
Annual | 2023 |
Revenue: | TWD1.79B |
Gross Profit: | TWD410.94M (23.02 %) |
EPS: | TWD-1.830 |
FY | 2023 |
Revenue: | TWD1.79B |
Gross Profit: | TWD410.94M (23.02 %) |
EPS: | TWD-1.830 |
FY | 2022 |
Revenue: | TWD2.25B |
Gross Profit: | TWD891.08M (39.58 %) |
EPS: | TWD0.340 |
FY | 2021 |
Revenue: | TWD1.64B |
Gross Profit: | TWD464.15M (28.28 %) |
EPS: | TWD0.110 |
Financial Reports:
No articles found.
Adimmune Corporation
Adimmune Corporation manufactures and sells human vaccines in Taiwan. It offers AdimFlu-S, a quadrivalent influenza vaccine; tetanus toxoid alum precipitated product that is used for the prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent influenza vaccines; Quadrivalent influenza vaccine; Influenza A (H1N1) Virus Monovalent Vaccine; Tetanus Toxoid; and purified Tuberculin, as well as contract manufacturing services. The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its name to Adimmune Corporation in 2001. Adimmune Corporation was founded in 1965 and is headquartered in Taichung, Taiwan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators